EKF Molecular, a part of EKF Diagnostics Holdings plc, is the provider of highly specific, sensitive and innovative technologies and products for molecular diagnostics to support personalized medicine. The company has launched four new products in its PointMan range, designed to enrich DNA for cancer research.
The new kits include PointMan KRAS Codons* 12/13/61 DNA Enrichment Kit, PointMan EGFR DNA Enrichment Kit, PointMan NRAS DNA Enrichment Kit and PointMan JAK2 DNA Enrichment Kit for detecting and studying KRAS, EGFR, NRAS and JAK2 genes responsible for colorectal cancer, non-small cell lung cancer, malignant melanomas and other diseases like polycythemia vera, essential thrombocythemia and myeloproliferative disorders respectively. These kits, designed for research purposes are useful in finding companion diagnostics for cancer treatment. The launch of these new PointMan kits also enhances EKF Molecular Diagnostics’ ability to change the existing DNA extraction and detection practices, addressing needs of the fast growing companion diagnostics market.
Source: EKF Diagnostics